HOME >> MEDICINE >> NEWS
Fertility worries common in young breast cancer survivors

BOSTON A survey of young breast cancer survivors found that more than half likely overestimated their risk for developing treatment related infertility, according to researchers from the Dana-Farber Cancer Institute.

The study, described in an oral presentation December 5 at the San Antonio Breast Cancer Symposium, is the largest to date that addresses fertility and menopausal concerns among young women with breast cancer.

The results serve as a wakeup call for health care providers, said Ann H. Partridge, MD, MPH, because "we don't have a great system for educating these women and showing them data even if incomplete about these questions and advising them on what they can consider to attempt to preserve fertility."

According to the result of the Web-based survey, 72 percent of the women said they had discussed fertility issues with their doctor and 17 percent had talked with a fertility specialist. Still, one-quarter of the women felt their unease about fertility was not adequately addressed.

As to whether a woman will retain her fertility, Partridge said the effects of older treatments are fairly well known, but there is less information on newer chemotherapy agents and ways of administering the chemotherapy. When asked to estimate their odds, more than half of women under 30 thought they had a 40 percent or greater chance of becoming infertile, when in fact research have revealed that very few women in this very young age group go through menopause with standard treatment, some studies showing a zero percent incidence in these patients, said Partridge. "Their risk perceptions are likely grossly exaggerated; there is room for education here."

Partridge, of the Breast Oncology Center at Dana-Farber, headed the study; senior author is Eric Winer, MD, the Center's director. The survey's 657 respondents were members of the Young Survival Coalition (YSC) an Internet-based advocacy group for young women with breast cancer. The mean age
'"/>

Contact: Janet Haley Dubow
janet_haley@dfci.harvard.edu
617-632-5665
Dana-Farber Cancer Institute
5-Dec-2003


Page: 1 2

Related medicine news :

1. Fertility herbal supplement sprouts promising results in Stanford pilot study
2. UF Researcher Explores Complex Relationship Between Smoking And Fertility
3. Cost, availability of insurance and drugs top health care worries
4. Why asthma sufferers struggle with the common cold
5. Use of potentially inappropriate medications among elderly common in some European countries
6. Adverse drug events in nursing homes are far more common than previously identified
7. Herbal extract as effective as commonly prescribed anti-depressant
8. Clinicians report missing patient information is common
9. Depression caused by common treatment for hepatitis C may affect outcome
10. FDA approves Pfizers Lyrica for the treatment of the two most common forms of neuropathic pain
11. Study determines commonly used contrast agent safe for universal use in CT

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Fertility worries common young breast cancer survivors

(Date:4/21/2015)... 2015 Carinsurancesavings.biz has released a new blog ... surveillance and explaining the impact on a uto insurance ... and supervised may be eligible for advantageous auto insurance discounts. ... simple and efficient way. This will also help them get ... simple way. , Finding low cost coverage is no longer ...
(Date:4/21/2015)... 2015 Optimity Advisors ( Optimity), ... firm that helps clients in complex industries navigate ... the Association of Community Affiliated Plans ... represents 58 local, not-for-profit, community-affiliated Safety Net Health ... people primarily enrolled in public or state-sponsored coverage ...
(Date:4/21/2015)... CO (PRWEB) April 21, 2015 ... Management , a new knowledge management solution that ... and publishing of policies and procedures. With Quark ... create reusable content that is easy to save, ... is susceptible to risk and compliance issues. Examples ...
(Date:4/21/2015)... When a bandage sticks to an injury ... to solve this problem two inventors from Festus, Mo., ... bandage helps a cut, burn, abrasion or wound heal ... exposure. The bandage is easy to use, versatile and ... submitted to the St. Louis office of InventHelp. It ...
(Date:4/21/2015)... Ill. (PRWEB) April 21, 2015 The ... the late cosmetic dermatologist Fredric S. Brandt, M.D., by ... Dr. Brandt, an ASDS member since 1982, died earlier ... The funds are designed to provide opportunities for ASDS ... field of cosmetic dermatology that Dr. Brandt held so ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 2Health News:ASDS honors the legacy of Dr. Fredric Brandt 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 4
(Date:4/21/2015)... 21, 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that the abstract describing ... from the Phase 2 clinical trial of the Company,s ... selected for an oral presentation at the 2015 American ... held in Chicago, Illinois May ...
(Date:4/20/2015)... 2015  Following is the daily "Profile America" feature ... MEDICINE Profile America — ... insulin —became available for general use this month in ... from diabetes. Insulin is a hormone produced by the ... in the human body. It was first isolated the ...
(Date:4/20/2015)... Ireland , April 20, 2015 ... that Charles M. Mayr , Chief Communications ... due to health reasons.  In conjunction with Mayr,s ... will assume the role of Chief Communications Officer, ... Kelly served as Senior Vice President, Chief Communications ...
Breaking Medicine Technology:Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 2Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 3U.S. Census Bureau Daily Feature for April 21 2Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3
Cached News: